|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.70 EUR | -1.11% |
|
-1.53% | -9.06% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LABORATORIOS FARMACEUTICOS ROVI, S.A. | Other Pharmaceuticals | -1.03% | -1.53% | -9.06% | +6.75% | -6.55% | 3.44B |  |  | |
- Stock Market
- Stocks
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
